Surgery for acromegaly: Indications and goals

Front Endocrinol (Lausanne). 2022 Aug 4:13:924589. doi: 10.3389/fendo.2022.924589. eCollection 2022.

Abstract

Acromegaly is a disease that occurs secondary to high levels of GH, most often from a hormone-secreting pituitary adenoma, with multisystem adverse effects. Diagnosis includes serum GH and IGF-1 levels, and obtaining an MRI pituitary protocol to assess for a functional pituitary adenoma. Attempted gross total resection of the GH-secreting adenoma is the gold standard in treatment for patients with acromegaly for a goal of biochemical remission. Medical and radiation therapies are available when patients do not achieve biochemical cure after surgical therapy.

Keywords: acromegaly; adenoma; endonasal; endoscopic; pituitary; skull-base; transnasal.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Acromegaly* / complications
  • Acromegaly* / surgery
  • Adenoma* / complications
  • Adenoma* / surgery
  • Goals
  • Growth Hormone-Secreting Pituitary Adenoma* / complications
  • Growth Hormone-Secreting Pituitary Adenoma* / surgery
  • Humans
  • Pituitary Neoplasms* / complications
  • Pituitary Neoplasms* / surgery